CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by August 3, 2026 in order to receive your certificate. Certificates will be available online until November 1, 2026 and are printable directly from the website.
The AAFP will review the 32nd Annual San Diego Heart Failure Summer Symposium and
deem it acceptable for up to TBD Live AAFP Prescribed credits. Term of Approval
is from 07/09/2026 to 07/11/2026. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as
equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's
Recognition Award. When applying for the AMA PRA, Prescribed credit earned
must be reported as Prescribed, not as Category 1.
Heart failure management is changing rapidly. The primary goal of the 32nd Annual San Diego Summer Heart Failure Symposium is to provide a comprehensive overview of advances in our understanding of the causes of heart failure and the best approaches for treating this disease in its varying forms. To accomplish this, we have assembled an exciting program that combines a series of focused lectures, case discussions and Q & A sessions that will help bring practicing clinicians up to date on the best approaches for treating their patients.
To provide adequate coverage of the expanding world of heart failure, the 32nd Annual Symposium will run over 2.5 days, rather than 2 days as in the past. This will allow individuals to get up to date information about a greater number of topics at a more leisurely pace. Attendees will also be able to tailor their schedules so that they can listen to the topics that they deem most relevant to their own practices
This year ‘s Symposium will include sessions on cardiogenic shock and pre-shock, the cardiorenal metabolic syndrome, the important role of aldosterone metabolism in heart failure and kidney disease, amyloid and other infiltrating cardiomyopathies, HFpEF, genetics and gene therapy, hypertrophic cardiomyopathy and HFrEF. Included in the program are the Founders Lecture that will help us better understand the role of adipose tissue in cardiac and renal disease and the annual Stanley H. Lloyd MD lecture that will provide an insight into the future management of heart failure. Additional talks will cover biomarkers, management of atrial fibrillation, prevention of sudden cardiac death, treatment of pulmonary hypertension, and an update on imaging modalities, These talks will provide a comprehensive overview of the new drugs, devices and strategies that are available (or on the horizon) for treating patients with heart failure and they will include practical approaches for patient selection and implementation. Notably, each day of the Symposium will start with a series of illustrative case vignettes, each one highlighting a different management strategy.
For this year’s symposium, we have recruited a world-renowned faculty representing multiple disciplines as well as patient advocates who will provide important perspectives on how patients are managed. As in the past, the Symposium will be presented in hybrid format. We encourage providers to attend the live presentations at the beautiful Hilton La Jolla Torrey Pines where they can interact with their colleagues, speakers and industry representatives over the 2.5 day symposium. For those who can’t attend in person, on-line streaming of all sessions will be available
At the conclusion of this activity, participants should be able to:
The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia LLC designates this activity for a maximum of TBD AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category Credits™ through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Heart failure (HF) currently affects well over million Americans. Moreover, prevalence is increasing in both developed and developing countries around the world. In the U.S. alone, an estimated 670,000 new cases of heart failure are diagnosed each year. HF adversely affects quality of life and increases hospitalization and mortality rates. It is the leading cause of hospitalization in elderly individuals in the United States. Moreover, within 8 years of diagnosis, 80% of men and 70% of women less than 65 years of age with new onset heart failure will die.
Our understanding of HF is changing rapidly and new treatments that help improve outcomes are available. The Symposium is designed to help clinicians synthesize new information about heart failure and integrate it into effective strategies of care of their patients. The Symposium will provide a comprehensive overview of diagnostic approaches, current evidence-based therapies and treatment strategies as well as emerging approaches for treatment.
This activity is in compliance with California Assembly Bills 1195 and 241 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity.